Mildred Solomon

The Hastings Center is the nation’s founding bioethics research institute, recognized worldwide for its analysis of the social and ethical implications of science, biotechnology and health care policy. Hastings scholars research and develop recommendations in a wide variety of areas, including ethical issues in genetics, synthetic biology, reproductive technologies, neuroscience, health care resource allocation, organ transplantation and end-of-life care. In addition to Solomon’s leadership role at The Hastings Center, she is a professor at Harvard Medical School, where she directs the school’s Fellowship in Bioethics, a program that builds the bioethics capacity of the Harvard teaching hospitals. The primary focus of Solomon’s own scholarship has been on the ethics of end-of-life care for adults and children, organ transplantation, protection of human research participants, responsible conduct of research, and the governance of emerging technologies. She has served on committees of, and consulted to, the National Academies of Science, Engineering and Medicine and is on the advisory council of the Public Health and Human Rights Program at the Open Society Foundations. Recently, she provided expert consultation to and a scholarly paper on end-of-life care for the Aspen Institute’s Aspen Health Strategies Group. She is serving a two-year term on the World Economic Forum’s Global Council on Technology, Values and Policy. Solomon publishes in a broad range of journals, including Health Affairs, JAMA, and The Hastings Center Report. She is widely quoted in the press, including the New York Times, the Washington Post, and NPR.